학술논문

Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial.
Document Type
Article
Source
Journal of Clinical Oncology; 2/10/2024, Vol. 42 Issue 5, p571-583, 21p
Subject
Language
ISSN
0732183X